Specifications Manual for Joint Commission National Quality Measures (v2021A1)
Posted: 9/25/2020
Home » High-intensity Statin at Discharge

Release Notes:
Data Element
Version 2021A1

Name:High-intensity Statin at Discharge
Collected For: CCCIP-01
Definition:Documentation that the acute myocardial infarction (AMI) patient was prescribed a high-intensity statin at hospital discharge.
Question:Was Atorvastatin, between 40-80mg, or Rosuvastatin, between 20-40mg prescribed at hospital discharge for AMI?
Allowable Values:

Y (Yes) Patient was prescribed either Atorvastatin 40-80mg or Rosuvastatin 20-40mg at hospital discharge.

N (No) Patient was not prescribed either Atorvastatin 40-80mg or Rosuvastatin 20-40mg at hospital discharge or it is it is unable to be determined from medical record documentation.
Notes for Abstraction:
  • Only select "Yes" for those statins identified in the list of inclusions at the dosages listed. No other no other statins will be accepted for this data element.
  • All medication documentation available in the chart should be reviewed and taken into account by the abstractor.
  • Select ‘Yes’, if the patient was discharged on Atorvastatin at a dose between 40-80mg or Rosuvastatin at a dose between 20-40mg or if the patient was on a high-intensity statin (i.e. Atorvastatin 40-80mg or Rosuvastatin 20-40mg) prior to admission and discharged on the same medication
  • Select ‘No’, if the patient was not discharged on Atorvastatin at a does between 40-80mg or Rosuvastatin at a dose between 20-40mg.
Suggested Data Sources:
  • Progress notes
  • Discharge summary
  • Discharge instructions
  • Written or electronic prescriptions
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion
Only Acceptable Medications and Doses
  • Atorvastatin 40mg - 80mg
  • Rosuvastatin 20mg - 40mg
  • All other statin medications other than those listed as inclusions.
  • Atorvastatin or Rosuvastatin prescribed at dosages other than those listed as inclusions.

High-intensity Statin at Discharge
CPT® only copyright 2019 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2021A1)
Discharges 01-01-21 (1Q21) through 06-30-21 (2Q21)


CPT® only copyright 2019 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.